The estimated Net Worth of Scott Daniel Cormack is at least $359 mil dollars as of 1 August 2017. Mr. Cormack owns over 4,715 units of Achieve Life Sciences stock worth over $41,452 and over the last 7 years he sold ACHV stock worth over $0. In addition, he makes $317,889 as Director at Achieve Life Sciences.
Sign up
Mr. Cormack ACHV stock SEC Form 4 insiders trading
Scott has made over 1 trades of the Achieve Life Sciences stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 4,715 units of ACHV stock worth $20,180 on 1 August 2017.
The largest trade he's ever made was exercising 4,715 units of Achieve Life Sciences stock on 1 August 2017 worth over $20,180. On average, Scott trades about 943 units every 0 days since 2017. As of 1 August 2017 he still owns at least 9,685 units of Achieve Life Sciences stock.
You can see the complete history of Mr. Cormack stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Scott Cormack biography
Scott Daniel Cormack serves as Director of the Company. Mr. Cormack has been a director since August 2008. Mr. Cormack also served as our President and Chief Executive Officer from August 2008 until the consummation of the Merger in August 2017. He also co-founded OncoGenex Technologies Inc., currently known as Achieve Life Sciences Technologies Inc., which is our wholly owned subsidiary, and served as its President from May 2000 and its Chief Executive Officer from February 2002 until the consummation of the Merger. He has also served as a member of its board of directors since May 2000. Mr. Cormack currently serves on the board of directors of The Vancouver Prostate Centre at Vancouver General Hospital and the Prostate Centre’s Translation Research Initiative for Accelerated Discovery and Development. Mr. Cormack served as interim President, Chief Executive Officer and Chairman of the Board of Directors of Salpep Biotechnology Inc., an asthma and inflammation biotechnology company, from 2000 to 2001. From 1998 to 2001, Mr. Cormack served as Vice President of Milestone Medica Corporation, a seed venture capital firm investing in life sciences opportunities. Mr. Cormack holds a B.S. degree from the University of Alberta. The determination was made that Mr. Cormack should serve on our Board of Directors due to his extensive experience leading public life science companies and deep industry knowledge.
What is the salary of Scott Cormack?
As the Director of Achieve Life Sciences, the total compensation of Scott Cormack at Achieve Life Sciences is $317,889. There are 9 executives at Achieve Life Sciences getting paid more, with Richard Stewart having the highest compensation of $796,644.
How old is Scott Cormack?
Scott Cormack is 55, he's been the Director of Achieve Life Sciences since 2017. There are 11 older and 5 younger executives at Achieve Life Sciences. The oldest executive at Achieve Life Sciences Inc. is Donald Joseph, 66, who is the Independent Director.
What's Scott Cormack's mailing address?
Scott's mailing address filed with the SEC is 19820 North Creek Pkwy #201, Bothell, WA 98011, USA.
Insiders trading at Achieve Life Sciences
Over the last 7 years, insiders at Achieve Life Sciences have traded over $972,224 worth of Achieve Life Sciences stock and bought 70,500 units worth $224,475 . The most active insiders traders include Capital, Llc Armistice Capi..., Vaughn B Himes y Jay M Moyes. On average, Achieve Life Sciences executives and independent directors trade stock every 65 days with the average trade being worth of $63,759. The most recent stock trade was executed by Jerry Wan on 19 April 2024, trading 5,625 units of ACHV stock currently worth $24,075.
What does Achieve Life Sciences do?
achieve life sciences is a specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic.
What does Achieve Life Sciences's logo look like?
Complete history of Mr. Cormack stock trades at Achieve Life Sciences
Achieve Life Sciences executives and stock owners
Achieve Life Sciences executives and other stock owners filed with the SEC include:
-
Richard Stewart,
Executive Chairman of the Board -
John A. Bencich M.B.A.,
CEO & Director -
Dr. Richard A. B. Stewart,
Exec. Chairman -
John A. Bencich,
CEO & Director -
Anthony Clarke,
Chief Science Officer -
Cindy Jacobs,
President -
Dr. Cindy Jacobs M.D., Ph.D.,
Pres, Chief Medical Officer & Director -
John Bencich,
Chief Executive Officer, Principal Executive Officer, Director -
Dr. Anthony Clark,
Chief Scientific Officer -
Scott Cormack,
Director -
Jason Wong,
IR Contact Officer -
H. Stewart Parker,
Independent Director -
Jay Moyes,
Independent Director -
Martin Mattingly,
Independent Director -
Donald Joseph,
Independent Director -
Jerry Wan,
Principal Accounting Officer -
Dr. Anthony Clarke,
Chief Scientific Officer -
Jaime Xinos,
Exec. VP of Commercial -
Jerry Wan,
Principal Accounting Officer -
Vaughn B Himes,
Director -
Financial Groupsvb Innovati...,
-
Capital, Llc Armistice Capi...,
-
Bridget A Martell,
Director -
Thomas Braxton King,
Director -
Stuart Duty,
Director -
Thomas Sellig,
Director